Podcasts about Genoa

La puntata 724 è l'ultima dell'anno per la nostra Redazione. Nel rinnovarvi anche qui i migliori auguri di Buon 2026, approfondiamo le ultime news dell'anno che si sta concludendo tra mercato e campo, tra sfida al Pisa e situazione Perin. Buoncalcioatutti!

Con la vittoria della Roma di ieri sera si è conclusa la 17° giornata di Serie A. La analizzano Nicola Bondavalli, Enrico Zambruno e Roberto Ugliono.Potrero, dove tutto ha inizio. Un podcast sul calcio italiano e internazionale.Su Como TV (https://tv.comofootball.com) nel 2026 potete seguire in diretta le partite della Saudi Pro League, Saudi King's Cup, Supercoppa d'Arabia, Copa Libertadores, Copa Sudamericana, Recopa, Liga Profesional Argentina, Trofeo de Campeones argentino, Eredivisie, Coppa di Francia, Scottish Premiership, Coppa di Scozia, Scottish League Cup, Scottish Championship, Coppa di Portogallo, Supercoppa di Portogallo, HNL croata e tutti i contenuti di calcio italiano e internazionale on demand.Diventa un supporter di questo podcast: https://www.spreaker.com/podcast/potrero--5761582/support.

Proviamo a commentare la prova indecorosa del Genoa in casa della Roma, abbinata ad una serie di errori della squadra arbitrale che necessitano una sottolineatura, così come necessita di una sottolineatura ulteriore il fatto che al Genoa servono rinforzi: gennaio è un mese chiave. Diteci la vostra nei commenti. Buoncalcioatutti!

Con la vittoria della Roma all'Olimpico contro il Genoa per 3-1, va in archivio il 2025 della Serie A: il massimo campionato di calcio ripartirà venerdi 2 gennaio 2026 con Cagliari-Milan, anticipo del venerdi valido per la 18esima giornata.

The award-winning author and historian Matthew Restall unpacks Columbus' enduring cultural and political presence while weaving a new history of the modern world.During a stay in Galicia, Spain, Restall was startled to encounter a local castle claiming to be Columbus' true birthplace. Locals insisted that Columbus, an Italian by birth, was born and raised in Galicia under the name of a local lord, Pedro Álvarez de Soutomaior. Thus began an in-depth investigation into the stories swirling around Columbus six centuries after his birth.In the years since Columbus “sailed the ocean blue in 1492,” his journey and its consequences have gained notoriety across the globe. Scrutinizing nine key myths, Columbus' “nine lives,” Restall tugs apart our misconceptions about the historical figure of Columbus, his exceptionalism, and his culpability for colonial violence in the Americas.Born in Genoa to a local cloth weaver, Columbus had an unextraordinary childhood. He left as a young man to pursue a maritime career – which would eventually lead him to the Spanish court of Queen Isabel and King Fernando where he received the lofty title “Admiral of the Ocean Sea.” In the years after Columbus' 1506 death, the mythology surrounding his life blossomed. From contentious debates over the location and possession of his remains to the campaign for his beatification in the 19th century, Columbus loomed large.He is the author of "The Nine Lives of Christopher Columbus." https://www.amazon.com/Nine-Lives-Christopher-Columbus/dp/1324086939

Learn more about your ad choices. Visit megaphone.fm/adchoices

Milan e Napoli fanno il loro dovere e conquistano tre punti preziosi, ma l'Inter risponde e si riappropria della vetta. Bologna e Sassuolo si colpiscono ma non si fanno male e non vanno oltre il pari. Stasera Roma e Genoa scendono in campo per l'ultima sfida della diciassettesima giornata. L'analisi a cura di Andrea Di Giacomo e Luca Tumminello.Potrero, dove tutto ha inizio. Un podcast sul calcio italiano e internazionale.Su Como TV (https://tv.comofootball.com) nel 2026 potete seguire in diretta le partite della Saudi Pro League, Saudi King's Cup, Supercoppa d'Arabia, Copa Libertadores, Copa Sudamericana, Recopa, Liga Profesional Argentina, Trofeo de Campeones argentino, Eredivisie, Coppa di Francia, Scottish Premiership, Coppa di Scozia, Scottish League Cup, Scottish Championship, Coppa di Portogallo, Supercoppa di Portogallo, HNL croata e tutti i contenuti di calcio italiano e internazionale on demand.Diventa un supporter di questo podcast: https://www.spreaker.com/podcast/potrero--5761582/support.

Claire vs. Audra; Kyle walks away from Claire; Lily sees Cane and Phyllis; Nick’s plan for Matt; Sally drags Adam; Billy’s Charlie Brown Christmas; Newman Abbott Romantic Christmas; Classic Episode 2010 Victor gets Scrooged. Visit https://www.yrchat.com to chat with fun and friendly fans of The Young and the Restless. THIS WEEK: Ali’s Y&R Recap, The […]

Roma-Genoa del 18 settembre del 1994 viene risolta dalla premiata ditta Babo-Fonseca.

Genoa, dalle parole di De Rossi a due giorni dalla sfida contro la Roma alle indicazioni di mercato, Perin su tutte. Che tempistiche attendersi? Quali le possibili scelte di formazione? Ne parliamo qui

Dopo le festività natalizie, domani torna in campo la Serie A con la 17ª giornata.Si parte alle 12:30 con Parma-Fiorentina: match caldissimo in chiave salvezza.

Genoa, ripercorriamo le ultime 48 ore tra campo ed extracampo, tra ripresa allenamenti e vicende giudiziarie di archiviazione sul capitolo aumento di capitale del dicembre scorso. E spazio anche al mercato. Il punto

In this episode we're discussing Tomas Rothaus's Another War is Possible (PM Press, 2025) an account of the movement against capitalism over the turn of the 21st century, written by an anarchist participant in the events. You can listen to an interview with Rothaus on Last Straw Radio here: Militant Anarchist Experiences in the Antiglobalization Era | The Final Straw Radio Podcast---------------------------------------------------------------You can keep in touch with the podcast our emailabcwithdannyandjim@gmail.com, and our Substack ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://abcwithdannyandjim.substack.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.If you enjoy this podcast, do tell your friends, colleagues and comrades to listen. The podcast music is Stealing Orchestra & RafaelDionísio, 'Gente da minha terra (que me mete um nojo do caralho).' Reproduced from the Free Music Archive under a Attribution-NonCommercial-NoDerivatives (aka Music Sharing) 3.0 International License, available here: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://bit.ly/35ToW4W⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠The podcast logo is an adapted version of the Left Book Clublogo (1936-48), reproduced, edited and shared under a Creative Commons Attribution-Share Alike 4.0 International licence. Original available here: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://bit.ly/35Nd6cv⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.The image in this episode is a photograph fromthe insurrection which accompanied the G8 summit in Genoa in 2001 .

Maracanà con Marco Piccari e Stefano Impallomeni. Ospite: Marco Palma ( Osservatore):" Coulibaly (07) tedesco difensore centrale Mascardi (06) portiere Lo Spezia, seguito da Milan e Genoa. Rossetti (07) centravanti Cesena under 20, seguito dall'Udinese

Steve Wyss, Dan Roebuck, and James Eastham break down this week's best bets in Serie A. Serie A Futures - 00:00 Parma v Fiorentina - 05:34 Lecce v Como - 10:12 Torino v Cagliari - 15:06 Udinese v Lazio - 17:12 Pisa v Juventus - 22:00 AC Milan v Hellas Verona - 27:12 Cremonese v Napoli - 32:12 Bologna v Sassuolo - 37:32 Atalanta v Inter - 40:54 Roma v Genoa - 45:27

Scarica Revolut gratis con il mio link per ricevere un bonus di benvenuto di €20*: https://get.revolut.com/e9Jc/podcast1 *Si applicano condizioni minime Il Napoli schianta il Bologna con la doppietta di Neres e si aggiudica la terza Supercoppa Italiana della sua storia. Nel frattempo, in Italia e tanti chilometri di distanza da dove gli azzurri hanno costruito il loro successo, si è giocata la 16° giornata di Serie A. L'analisi della vittoria di Conte e del turno appena concluso a Potrero con Simone Indovino, Enrico Zambruno e Giuseppe Broggini. Potrero, dove tutto ha inizio. Un podcast sul calcio italiano e internazionale.  Su Como TV (https://tv.comofootball.com) nel 2025 potete seguire in diretta e gratuitamente le partite della Saudi Pro League, Saudi King's Cup, Supercoppa d'Arabia, Copa Libertadores, Copa Sudamericana, Recopa, Liga Profesional Argentina, Trofeo de Campeones argentino, Eredivisie, Coppa di Francia, Scottish Premiership, Coppa di Scozia, Scottish League Cup, Scottish Championship, Coppa di Portogallo, Supercoppa di Portogallo, HNL croata e tutti i contenuti di calcio italiano e internazionale on demand.Diventa un supporter di questo podcast: https://www.spreaker.com/podcast/potrero--5761582/support.

Maracanà con Marco Piccari e Stefano Impallomeni. Ospite: Marco Palma ( Osservatore):" Coulibaly (07) tedesco difensore centrale Mascardi (06) portiere Lo Spezia, seguito da Milan e Genoa. Rossetti (07) centravanti Cesena under 20, seguito dall'Udinese

In this special holiday edition of Somewhere in the Skies, Ryan invites listeners to gather around the glow of Christmas lights and explore a surprising tradition of the season: UFO encounters that unfold on the quiet, magical nights of Christmas Eve. From a shimmering disc drifting over festive Genoa, to mysterious orbs pacing New Zealand aircraft, to a gentle sphere of light visiting a nursery in South Shields, and onward to the enormous craft seen in snowy Ohio, Kingsburg, and the Texas night sky, these sightings form the Christmas Eve UFO Wave, a reminder that even during the warmth, wonder, and stillness of the holidays, something extraordinary can slip into our world. Please take a moment to rate and review us on Spotify and Apple. Book Ryan on CAMEO at: https://bit.ly/3kwz3DO Patreon: http://www.patreon.com/somewhereskies ByMeACoffee: http://www.buymeacoffee.com/UFxzyzHOaQ PayPal: sprague51@hotmail.com All Socials and Books: https://linktr.ee/somewhereskiespod Email: ryan.Sprague51@gmail.com SpectreVision Radio: https://www.spectrevision.com/podcasts Opening Theme Song by Septembryo Copyright © 2025 Ryan Sprague. All rights reserved. #ChristmasUFOs #ChristmasUAP #HolidayUFOs #AliensAtChristmas #FestiveUAP #SantaUFO #WinterUFOs #ExtraterrestrialLife #UnidentifiedAerialPhenomena #AlienEncounters #SpaceMysteries #CosmicPhenomena #GovernmentDisclosure #UAPInvestigation #ParanormalHolidays Learn more about your ad choices. Visit megaphone.fm/adchoices

Genoa.... Genoa.... GENOA! Eggnog er no? NYE celebration or Netflix? See omnystudio.com/listener for privacy information.

Savaitinėje 15min laidoje „Skrieja kamuolys“ apžvelgiamos Lietuvos ir užsienio futbolo aktualijos. Šią savaitę didžiausias dėmesys skiriamas LFF ir Klaipėdos „Neptūno“ flirtui, prasidėjusiam Afrikos futbolo čempionatui bei tradiciškai apžvelgiama situacija visose stipriausiose Europos futbolo lygose. Prie mikrofonų – tradicinis trejetukas: 15min žurnalistai Marius Bagdonas ir Aurimas Tamulionis bei „Go3“ komentatorius Karolis Dudėnas. 00:00 Intro 00:10 Savaitės darbai ir Mariaus apsilankymas „Man Utd“ stovykloje 6:10 Klaipėdos „Neptūnas“ ir LFF: keista meilė iš išskaičiavimo? 18:00 Tapinas, „Žalgiris“ ir kolūkio valgykla 25:21 „Hegelmann“ judesiukai ir kiti A lygos reikalai 36:10 Lietuvių sėkmė UEFA Konferencijų lygoje 44:14 Valdas Dambrauskas kelia vėją Azerbaidžane 45:06 Lietuvos salės futbolo rinktinė ir artėjantis Europos čempionatas 46:50 „Arsenal“ vargai Liverpulyje, bet smagios Kalėdos 53:53 Nestojantis „Man City“ ir nuotaikingas Pepas 57:50 Smagi „Aston Villa“ ir klausimų neišsklaidantis „Man Utd“ 1:03:30 „Newcastle United“, „Chelsea“ ir patenkinti abu treneriai 1:08:01 Puolėją atradęs „Liverpool“, „Tottenham“ 1:15:12 Kiti Anglijos futbolo reikalai 1:18:37 „Barcelona“ ir Raphinha 1:24:20 „Real“ ir Kyliano Mbappe rekordai 1:30:45 „Bayern“ dominavimas, „Borussia“ kivirčai ir Vokietija 1:37:55 Gvidas Gineitis – „Torino“ sėkmės garantas? 1:41:23 Į „Genoa“ pagrindą siunčiamas Lysionokas 1:45:14 AFCON pradžia 1:58:00 Škotijos futbolo įdomybės

Commentiamo la partita tra Genoa e Atalanta, una beffa per i rossoblù sconfitti al 94' con un gol di Hien. Leali espulso al 3' di gioco lascia la squadra di De Rossi in inferiorità numerica, ma la prova del Grifone è ben più che positiva. Buoncalcioatutti!

Maracanà con Marco Piccari e Stefano Impallomeni. Ospiti: Garbo:"La Juve non può rientrare nel giro scudetto, manca un regista" Ceccarini:"La Juve arriva. Finalmente ha vinto la Fiorentina" Bonanni:"Napoli favorito per la finale di SuperCoppa" Impallomeni:"De Rossi ha dato contenuti tecnici al Genoa"

Versione ridotta del campionato per questo sedicesimo turno. Una giornata senza le partite di Inter, Milan, Bologna e Napoli impegnate a Riad per la Supercoppa italiana.

Scarica Revolut gratis con il mio link per ricevere un bonus di benvenuto di €20*: https://get.revolut.com/e9Jc/podcast1 *Si applicano condizioni minime Si chiude la domenica di Serie A con il colpo di reni dell'Atalanta a Marassi. La Fiorentina vince la sua prima partita in campionato con una manata contro l'Udinese, pari rocambolesco a Cagliari e vittoria importante del Toro a Reggio Emilia. Alle 20:00 in campo Napoli e Bologna per la finale di Supercoppa Italiana. Potrero, dove tutto ha inizio. Un podcast sul calcio italiano e internazionale.  Su Como TV (https://tv.comofootball.com) nel 2025 potete seguire in diretta e gratuitamente le partite della Saudi Pro League, Saudi King's Cup, Supercoppa d'Arabia, Copa Libertadores, Copa Sudamericana, Recopa, Liga Profesional Argentina, Trofeo de Campeones argentino, Eredivisie, Coppa di Francia, Scottish Premiership, Coppa di Scozia, Scottish League Cup, Scottish Championship, Coppa di Portogallo, Supercoppa di Portogallo, HNL croata e tutti i contenuti di calcio italiano e internazionale on demand.Diventa un supporter di questo podcast: https://www.spreaker.com/podcast/potrero--5761582/support.

Newman Media slams Jabot. Adam and Chelsea debate Victor; Phyllis agrees to steal the AI… again!; Nikki threatens to leave Victor; Audra’s true feelings for Kyle; Christmas in Genoa City; and Noah gets knocked out! Visit https://www.yrchat.com to chat with fun and friendly fans of The Young and the Restless. THIS WEEK: Ali’s Y&R Recap, […]

https://thecommunists.org/2025/12/01/news/industry/the-spark-dockers-war-junior-doctors-bin-men-tube-strike-and-more/ Dockworkers in the Italian port of Genoa have consistently led the way in obstructing the efforts of the Nato war machine. As well as stopping arms shipments to Israel they have also stopped shipments of munitions to Ukraine and to Saudi Arabia (for use in its genocidal war against Yemen). Their example is one that should be followed by workers everywhere Subscribe! Donate! Join us in building a bright future for humanity! www.thecommunists.org www.lalkar.org www.redyouth.org Telegram: t.me/thecommunists Twitter: twitter.com/cpgbml Soundcloud: @proletarianradio Rumble: rumble.com/c/theCommunists Odysee: odysee.com/@proletariantv:2 Facebook: www.facebook.com/cpgbml Online Shop: https://shop.thecommunists.org/ Education Program: Each one teach one! www.londonworker.org/education-programme/ Join the struggle www.thecommunists.org/join/ Donate: www.thecommunists.org/donate/

This week we led off with the Prem where Man City impressed at Selhurst Park, and Aston Villa continued their hot streak with a victory at West Ham in a thriller! Barça kept the gap at the top with a win at Camp Now over Osasuna, Inter jump to top spot in Serie A with a win away at Genoa, and bottom club Mainz went to the Allianz and took a point off Bayern!  We cover the groups in the World Cup draw, plus Wanderers have a big gaffer hire with the appointment of Vanni Sartini! 

Andrew, Irfan, and Jae discuss Inter's loss to Liverpool and away win to Genoa. They also preview the Supercoppa.

Join Jake and Matt as they run you through all the action (and controversy) of Matchday 15 in Serie A !Inter have gone top, after beating Genoa and Milan faltering to their bogey team Sassuolo. Udinese dismantled Napoli, Roma outclassed Como, while 9-man Lazio pulled off a masterclass to get all 3 points against Parma. Juventus edged Bologna, while Fiorentina's nightmare continues as they lost to Hellas in the dying moments of the game. Lecce and Torino showed newcomers Pisa and Cremonese why they are mainstays in Serie A.

Audra and Holden’s secret revealed; Sienna and Matt come to GC; Cane and Lily plan a not-date, then Cane and Phyllis kiss!; Michael and Lauren’s 20th Anniversary; and Victor vs. Jack 2025! Visit https://www.yrchat.com to chat with fun and friendly fans of The Young and the Restless. THIS WEEK: Ali’s Y&R Recap, The Weekly Y&R […]

After more than four decades in professional kitchens—including twenty years as chef-owner of Portland's beloved Nostrana—Cathy Whims has published her first cookbook. The Italian Summer Kitchen captures the essence of Italian summer cooking through the lens of the Pacific Northwest, featuring simple, ingredient-driven recipes and beautiful watercolor illustrations.This conversation was recorded in Bologna, Italy, at Sette Tavoli, one of Brian's favorite restaurants. We discuss Cathy's journey from vegetarian teenager to celebrated chef, her time training with Marcella Hazan and Dario Cecchini, the cult following around Nostrana's signature Insalata Nostrana, and how the pandemic changed her approach to this book.In this episode:• Growing up cooking with Julia Child cookbooks• Working through every station at Genoa, Portland's premier fine dining restaurant• The pivotal trips to Italy that changed everything• Opening Nostrana and celebrating 20 years this year• Training with Marcella Hazan and the tomato butter sauce that's been on the menu since day one• The secret to the perfect radicchio salad• Why she chose watercolor illustrations over photographs• How COVID-19 shifted the book from restaurant cooking to home cooking• The "less is more" philosophy of cucina povera• An ingredient challenge gamePlus, on our Substack: Two recipes from the book—Spaghettini with Prawns and Yogurt Panna Cotta—and hear Cathy read an excerpt from The Italian Summer Kitchen.Special thanks to Jaqueline and the team at Sette Tavoli in Bologna for hosting this recording.Guest Cathy WhimsBook The Italian Summer Kitchen by Cathy WhimsEpisode Length 45:28Timestamps00:00 - Introduction & recording in Bologna02:15 - Growing up in Chapel Hill, NC04:30 - The vegetarian awakening and her mother's response07:45 - Latin major turned professional cook10:20 - Landing the dream job at Genoa12:45 - Working through every station15:30 - The trips to Italy that changed everything18:00 - "The hundred dollar chicken" and knowing it was time to move on21:00 - Opening Nostrana: a new vision23:30 - Training with Marcella Hazan26:15 - The Insalata Nostrana: origin story and technique30:45 - The ice water secret33:00 - Other influential cookbook authors35:30 - The pandemic pivot: from restaurant book to home cooking39:00 - Why illustrations instead of photographs42:15 - Summer preservation techniques45:00 - The ingredient challenge game45:30 - Challenge #1: Seafood (spot prawns, bottarga, zucchini blossoms, truffle butter)49:15 - Challenge #2: Agrodolce (hazelnuts, red wine vinegar, peaches, marshmallows)53:00 - Challenge #3: Tuscan Crossover (chanterelles, guanciale, ricotta, kimchi)57:30 - ClosingCreditsHost: Brian Hogan StewartRecorded at: Sette Tavoli, Bologna, ItalySalt + Spine is part of the Heritage Radio Network. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit saltandspine.substack.com/subscribe

Guests Dr. Andrea Necchi, Dr. Ashish Kamat and host Dr. Davide Soldato discuss JCO article "End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer," focusing on the evolving treatment landscape of MIBC (muscle-invasive bladder cancer) and the need to properly design novel trials investigating non-operative management while including the incorporation of biomarkers and patient perspectives in clinical trials. TRANSCRIPT The disclosures for guests on this podcast can be found in the show notes. Dr. Davide Soldato: Hello and welcome to JCO After Hours, the podcast where we sit down with authors from some of the latest articles published in the Journal of Clinical Oncology. I am your host, Dr. Davide Soldato, medical oncologist at Ospedale San Martino in Genoa, Italy. Today we are joined by JCO authors Andrea Necchi, Associate Professor of Medical Oncology at University San Raffaele and Medical Oncology at Ospedale San Raffaele in Milan, Italy, and Ashish Kamat, Professor of Urologic Oncology and Cancer Research at University of Texas MD Anderson Cancer Center. Both Professor Necchi and Professor Kamat are internationally recognized experts in the field of genitourinary malignancy and particularly in bladder cancer. Today we will be discussing the article titled "Endpoints for the Next Generation Bladder-Sparing Perioperative Trials for Patients with Muscle-Invasive Bladder Cancer." So thank you for speaking with us, Professor Necchi and Professor Kamat. Dr. Andrea Necchi: Thank you, Davide, and thank you JCO for the opportunity. Dr. Ashish Kamat: Yeah, absolutely. It is a great honor and privilege to be discussing this very important article with you. So thank you for the invitation. Dr. Davide Soldato: The article that you just published in JCO reports the results of a consensus meeting that was held among experts in the field of genitourinary malignancy and particularly for bladder cancer. So the objective was really to define endpoints for a novel generation of trials among patients diagnosed with muscle-invasive bladder cancer. So my first question would be: what is the change in clinical practice and in clinical evidence that we have right now that prompted the start of such consensus in 2025? Dr. Andrea Necchi: So, we are living so many changes in the treatment paradigm of patients with muscle-invasive bladder cancer. In general, patients diagnosed with bladder cancer or urothelial cancer today, thanks to the advent of immunotherapy or immunotherapy combinations, and today thanks to the advent of novel antibody-drug conjugates like enfortumab vedotin in combination with immunotherapy that are actually changing the landscape of treatment of patients with metastatic disease and also are entering quite fast into the treatment paradigm of patients with organ-confined disease with a lot of clinical trials testing these combination therapies, neoadjuvantly or adjuvantly, before or after radical cystectomy. Having said that, by potentiating the efficacy of systemic therapy, an increasing number of patients that receive neoadjuvant therapy of any kind, at a certain point in time, result to have achieved a deep response to systemic therapy, evaluated radiologically with conventional imaging, CT scan or MRI, or with cystoscopy or with other urology-based techniques, urinary cytology, and so. And based on the fact that they achieve a complete response, so no residual viable disease after systemic therapy, they raise concern about the fact that they have to undergo surgery like radical cystectomy that is quite impactful for their quality of life and for the future of their lives after the surgery. So the point that the patients are raising, and the patients are raising this point, is primarily due to the efficacy of systemic therapy. And we have seen so many cases fortunately achieving a deep response. So the question about what to do with the patient that at a certain point, at the start with the commitment to radical cystectomy, but at a certain point in time change their mind towards something else if possible, depending on the fact that they have achieved a deep response, is something that is a question and is a need to which we have to provide data, information, and guidance in general to the patients. Dr. Davide Soldato: If we look at the population that the recommendations were formulated for, we are mainly speaking about patients who would be fit for cystectomy, and this is a very distinct population compared to those who are not fit for cystectomy, both from a medical oncology point of view but also from a urologic point of view in terms of surgery. So, can you explain a little bit to our listeners why you think that this distinction is critical and why you developed this recommendation especially for this population? Dr. Ashish Kamat: That is a very important distinction that you made. To build upon what Professor Necchi mentioned earlier, this question that we get from patients after neoadjuvant therapy or systemic therapy is not a new question. It has been something that they have been asking us for the last 20 or 30 years. "Do I really need to have my bladder taken out?" And patients who are especially not fit for surgery will sometimes say, "Do I need to have my bladder taken out? And if I cannot have my bladder taken out, am I going to just not have anything done?" Because the eligibility for radical cystectomy is also a moving target. Over the years with improvement in surgical technique, improvement in perioperative therapy, ERAS protocols, et cetera, it is really unusual for us to deny a patient the opportunity to have major surgery unless clearly they have very significant comorbid conditions. So I think this endeavor is more broadly encompassing of the patient population than what was evident in previous years. And I really want to give a shout out to Professor Necchi because what we did was, as part of the International Bladder Cancer Group and Professor Necchi is an integral part of the scientific advisory board, we broached this topic broadly during one of our discussions. And of course, Andrea always does this, he picks on a topic and then he says, "Okay, we need to discuss this really in detail," put together a multinational, multicenter collaborative group, but the driving force was our patients. Because our patients are constantly asking, "Do I need to lose my organ? Do I need to have radiation therapy?" which again, also, has a lot of side effects. So this was really to answer the question in today's day and age as to do we need to do local consolidation, and if so, in what way? It is not a new question, but we have newer therapies, newer technology, and better ways to answer this. So it is a much needed question that needs to be answered. And I think the distinction between non-surgical candidates and surgical candidates is a little bit blurred in today's day and age. Dr. Davide Soldato: What about the eligibility, for example, for cisplatin-based chemotherapy? Because I think that that is a very fundamental part of this type of strategy that we apply to patients with muscle-invasive bladder cancer. So we know that there are some caveats for proposing such treatment. And also this population was specifically defined inside this recommendation. Dr. Andrea Necchi: I think that the focus of our work is just to analyze what is happening after any type of systemic therapy the patient may get neoadjuvantly. So it is not actually a question of treatment eligibility or including cisplatin eligibility. This is an old question of today's practice and clinical trials. But regardless of what the patient received neoadjuvantly, the point that we have addressed in our consensus meeting was what to do next as a further step after systemic therapy or not. So basically we are- the consensus guidance includes all-comers, so patients to get any type of systemic therapy. So really non-selected based on specific features that determine a special eligibility to a special or a particular therapy. But an all-comer approach is always the winning approach for the translation to be in practice, an all-comer approach just focusing on what has happened after treatment and that we are assessing by the use of conventional imaging, MRI or CT, cystoscopy, urinary cytology, and trying to merge all together this information, all these features in a unique, shared, reliable definition of clinical complete response that could be used as a biomarker for the selection of newer therapies instead of pathological response that has been historically used, and maybe surrogate for the outcome, the long-term outcome and survival of these patients. Dr. Davide Soldato: A very specific point of the consensus was actually the definition of clinical complete response. As you were saying, this is actually a combination of several parameters including urinary cytology, the use of cross-sectional imaging, for example CT scan, but also the evaluation in cystoscopy of the bladder. Do you foresee any potential problems when applying this type of recommendation, not inside clinical trials, but in the context of routine clinical practice? Dr. Ashish Kamat: Absolutely. And that was the whole reason we had this consensus meeting. What happens nowadays in daily practice, and we see this every day at our center, we see patients referred to us. This definition or this sort of attempt to define clinical complete response is an ongoing issue. And urologists, medical oncologists, radiation oncologists are always looking to see, does my patient have a complete response? That definition and those paradigms have changed and evolved over the years. The FDA had a workshop many years ago looking at this very question. And it was to address the proposal that complete clinical response, which is a clinical definition, a clinical state, does this correlate with pathologic response? And with the technology and the systemic therapies we had then, the answer was 'no'. In fact, more patients got recurrent disease than did not get recurrent disease. And that is why, of course in the paper we mention the trials that looked at this question, the trials that evolved around this question. And I think the distinction between a clinical trial and daily practice is extremely important when we are looking at this definition per se. Because essentially what happens with this issue is that if the patient is not appropriately counseled, and if the physician does not do the appropriate clinical complete response assessment as Professor Necchi mentioned, right, cystoscopy, cytology, imaging, use of markers that are still in evolvement, we risk doing harm to the patient. So we caution in the paper too that this definition is not ready for prime time use. It is something that needs to be studied. It is a rigorous definition and currently we are recommending it for clinical trials. I am sure eventually it will trickle down into clinical practice, but that guidance was not the purpose of this consensus meeting. Dr. Davide Soldato: There are several parameters that are potentially evolving and could potentially enter inside of clinical practice. For example, you mentioned pelvic MRI and we have now very specific criteria, the VI-RADS criteria, we're able actually to diagnose and also to provide information. So along with these novel imaging techniques, we also know that there are novel biomarkers that could be explored, for example ctDNA and urinary DNA. So what I was wondering is, why were not these included inside the definition that you provide for clinical complete response? And do you think that, as we are designing these trials to potentially spare cystectomy for this patient, we should include these biomarkers very early so that we can actually provide better stratification for our patients and really propose this type of cystectomy-sparing strategy only to those where we are very confident that we have obtained a clinical complete response? Dr. Andrea Necchi: I would say you have just to wait. So a follow-up is ongoing and hard work is ongoing. At the time we met, at the time we established the meeting in mid-December last year, we had no information on the ctDNA data from major trials, with only a few exceptions. So we were just at the beginning of a story that was more than likely to change but still without numbers and without data from clinical trials. Now in just nine months or 10 months time, we have accumulated important data and newer data will be presented during just a few weeks and a few days regarding the ctDNA, circulating tumor DNA in particular, as a prognostic marker assessed baseline or assessed after neoadjuvant therapy. So the point is certainly well made and ctDNA is certainly well shaped to be incorporated in a future definition of clinical complete response. But you have to consider the fact that most of the data that we are accumulating related to ctDNA are about the post-cystectomy field or the metastatic field. So regarding neoadjuvant therapy, you know, we have neoadjuvant therapy in the context of bladder-sparing approach, basically we have no information. And the point that is emerging in our daily practice when using these biomarkers or in clinical trials, and the impression in general, is that it is a very strong biomarker associated with survival, but we absolutely do not know what is the performance of the test in the prediction of superficial bladder relapses, high-grade pTa relapse in the bladder that is left untouched in the patient. We are considering, and maybe it will be just a matter of further discussion, not just what is happening within the immediate endpoint of clinical CR, but also what is happening later with other survival endpoints. And for example, when looking at the type of events that we may see in this kind of bladder-sparing approaches, most of the events, also in the trials that have been published including the RETAIN study published in JCO, most of the events are related to superficial high-grade superficial non-muscle invasive relapses. So the ability to predict these types of events with ctDNA is completely unknown. Maybe, maybe other liquid biomarkers like urinary tumor DNA, utDNA, could be a bit better shaped in the prediction of this kind of events, you know. But we have still to build the story. So the question is good. The answer is yes, we will likely, more than likely incorporate liquid biomarkers in the definition, but we have to wait at least more data and more robust data in order to translate this information in routine practice, you know. Another consensus meeting is organized by IBCG and the same folks for November. This meeting will be primarily focused on the liquid biomarkers, the interpretation and use and approval and so of liquid biomarkers including bladder cancer. And we will likely be able to address all these, most of these open issues, so most of these points in the next meetings. Dr. Davide Soldato: In the consensus you say that probably clinical complete response is now ready to be included in early phase trials, so actually to test what is the efficacy of the regimens that is being evaluated inside of these trials. But you actually do very in-depth work of defining what are the most appropriate endpoints for later phase trials. So to be very specific, the phase three registrational trials that bring new regimens inside of this space. So I just wanted to hear a little bit about what was the definition for event-free survival, which you define as the most appropriate one for this type of trials. And as you were mentioning before, Professor Necchi, there is a very specific interest on the type of events that we observe, especially when we look at these superficial relapses inside of the bladder. So was this a very urgent matter of debate as we define which type of events should actually trigger event-free survival? And did you make a very thoughtful decision about why using this type of endpoint instead of others, for example metastasis-free survival? Dr. Ashish Kamat: Yeah, this was a matter of intense debate as you might imagine. And again, this is a moving target. So as Professor Necchi mentioned, we tend to partner with each other, our organizations, on having definitions of clinical complete response, biomarker, retreats, and then using that as a marker, and you might imagine this definition of what is appropriate event-free survival, what events matter to the patient, is something we have been talking about for two years. It was not just something that came up at the retreat. But at the retreat there was intense discussion. One of the things that we talked about was bladder-intact event-free survival because we are trying to spare the patient's bladder. And do we count bladder-intact event-free survival as something that is relevant? The patient advocates absolutely liked that, right? They wanted that. But then we also learned from some of the studies, for example from the RETAIN study, that the non-muscle invasive recurrences can actually lead to metastatic disease. It is not as benign when you have a patient with muscle-invasive bladder cancer that then develops a non-invasive tumor because maybe there is cancer growing underneath the surface that we don't detect when we look in the bladder. So a lot of those discussions were held, debated. It was a consensus. I have to say it was not 100% agreement on that particular definition, but it was broad consensus. And Andrea, do you want to clarify a little bit as to how we came about that consensus? Because I think this is a very important point we need to make. Dr. Andrea Necchi: We focused on a bit different definition of BI-EFS, Bladder-Intact Event-Free survival. Just stating EFS as an all-inclusive parameter including all type of high-grade relapse or progression or death that may happen to the patient. So that we were counting high-grade pTa, pT1, CIS relapses to the bladder and of course more deeper involvement in the muscle layer and so, and metastatic disease as a relapse. But the point is that as compared to the classical bladder-intact EFS definition of chemoradiation bladder-sparing approaches that is including muscle-invasive relapses only or death as events, we tried to be as inclusive as possible in order to be as much conservative as possible and to raise as higher the bar as possible for the success. And this is actually what the patients are asking us. So they are asking, "Okay, I can save my bladder, sparing radical cystectomy, but at which cost?" So in order to provide an answer, we have to be very, very cautious and be on the right shape, on the right position to say, "Okay, we have accomplished the most, the safest points, you know, by which you can proceed with the bladder-sparing." This is the first point. The other point is related to the MFS, metastasis-free survival that you have mentioned. For sure, it was recognized as a very important point for sure. But in the discussion was clear that our focus was in saving patients, curing the patient, and saving the bladder. Any single event, superficial event that may occur in the bladder-saving approaches of this kind may expose the patient to an extra risk of developing distant metastases, as it happened for example in the RETAIN study. So EFS defined as we have agreed and published, is actually a way of including or anticipating in a safest position the MFS. Because most or if not the entirety of the events of metastasis development in patients undergoing bladder-sparing after neoadjuvant systemic therapy were preceded by a superficial phase of disease relapse, you know. So I remember very, very few, or we can count just on the finger of one hand, the cases that have been reported in the literature developing de novo metastatic disease in the similar bladder-sparing approaches, in particular when using a maintenance immunotherapy strategy, you know, after they reach TURBT. So this is the reason why with all the limitation that Ashish has mentioned, with all the uncertainties that are still there, the nervousness that is still there, EFS, as defined in the protocol, as put in the paper, is to us at the moment is the safest way to use a primary endpoint in potentially registration trials of this kind with perioperative systemic therapy and response-adapted surgery. Dr. Ashish Kamat: And David, just to be absolutely clear for our listeners, right, so what was the event-free survival that we defined? Essentially it was a very inclusive definition. Event was defined as high-grade tumor persistence, recurrence, or progression during or after perioperative therapy, and receipt of any additional standard of care treatment including radical cystectomy, radiotherapy or even intravesical therapy. So this was done at the behest of our patient advocates because we really wanted to make a very robust definition that could be utilized appropriately as an adequate primary endpoint for both early and late phase bladder preservation trials. Dr. Davide Soldato: I think that it really highlights one of the points that I liked the most about this consensus is that it really incorporated the patient vision and a sort of shared decision making process when we are deciding how we want to design these trials that will explore this bladder-sparing surgery. And Professor Necchi mentioned something that I think will be also a very interesting question for trials that will be developed considering the activity of this combination that we are seeing right now, which is maintenance. Because right now our approach in the few cases where patients do not do any type of treatments after an induction with neoadjuvant treatments is basically represented by observation. So I was wondering if you think that the field will actually evolve to a sort of maintenance strategy even in patients that will achieve a complete clinical response? Dr. Andrea Necchi: We just mentioned briefly in the paper, this is a very important point that was touched during the discussion, and in particular was raised and discussed by FDA people participating in the meeting. And when looking at the data from the trials that were available and are still available thus far, we could provide a suggestion that maintenance immune therapy is the preferred approach in this kind of approach as it currently stands, as the data currently stand. Because the cleanest data towards the successful part of this journey is related to the studies that provided a kind of maintenance therapy, like the study with nivolumab or the RETAIN-2 study with maintenance immune therapy instead of RETAIN study that was just stopping treatment until surgery with MVAC chemotherapy. So in general the impression is that maintenance therapy may help in reducing the type of events, including the events that we incorporate in the EFS definition that we mentioned in the paper. The point that you mentioned is very important because on the other side we have a problem, a big problem of affordability and cost of the treatment. The de-escalation trials are an urgent need and represent a call for the studies. Unfortunately, as you mentioned, this is something that moves beyond the possibilities of this type of consensus because we don't have data and we have to accumulate data from clinical trials prior to saying, "Okay, certain patients could de-escalate therapy and stop therapy and some other not." So we are still at the very beginning. So we can do- we can discuss about this in the radical cystectomy paradigm but not in the bladder-sparing paradigm, you know. But this is for sure a point, a discussion point that will be taken, pretty well taken in one year or two year projection. Dr. Davide Soldato: I was wondering if in the consensus, considering that patient advocates and patient associations were also involved, did you decide to actually suggest the inclusion of patient-reported outcomes or the evaluation of shared decision-making in the development of this trial really as endpoints that should matter as much or as much as possible as event-free survival and clinical complete response? Dr. Ashish Kamat: Oh yeah, absolutely. We had patient advocates, we had the World Bladder Cancer Patient Coalition, Bladder Cancer Advocacy Network, patient representatives. And we always consider this. Shared decision-making is actually the impetus behind why these efforts have been launched, right? So it is the shared decision-making that is very, very important. It is the driving force behind what we do. And it is worth noting, for example, for the design of such studies, regulatory agencies consider response-based endpoints or overall survival as primary endpoints. But the patient advocates consider quality of life to be just as important, if not more important sometimes than overall survival numbers. Because patient advocates will say, "Well if I live longer but I'm miserable living longer, yes that works for regulatory agencies but doesn't work for us." So PROs clearly are very, very important. And, in fact, we just literally had a meeting in Houston, the IBCG meeting where PROs were a main point of what we discussed. So incorporating PROs in everything we do, not just this but everything we do, Dr. Necchi, myself, everybody involved in these fields realizes it is very, very important. So absolutely. Dr. Davide Soldato: I want to thank again Professor Necchi and Professor Kamat for joining us today. Dr. Andrea Necchi: Thank you. Dr. Ashish Kamat: It is our pleasure. Dr. Davide Soldato: Thanks again and we appreciate you sharing more on your JCO article titled "Endpoints for the Next Generation Bladder-Sparing Perioperative Trials for Patients with Muscle-Invasive Bladder Cancer." If you enjoy our show, please leave us a rating and review and be sure to come back for another episode. You can find all ASCO shows at asco.org/podcast. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.

Join Jake and Matt as they run you through Matchday 14 of the 25/26 Serie A Season on their special 200th episode. We wish to thank everyone who's joined us on this journey and hope you'll continue listening to us banter about calcio!Timestamps0:00 Intro and Rundown 21:59 Napoli 2-1 Juve 43:06 Inter 4-0 Como 58:17 Torino 2-3 Milan 1:15:34 Cagliari 1-0 Roma 1:29:45 Sassuolo 3-1 Fiorentina 1:45:41 Lazio 1-1 Bologna 1:58:23 Hellas 3-1 Atalanta 2:05:58 Cremonese 2-0 Lecce 2:14:50 Pisa 0-1 Parma 2:22:38 Udinese 1-2 Genoa 2:28:56 Quickfire Predictions 2:32:07 Wisdom with the Wank 2:36:07 The Pride of Indonesia 2:38:25 Outro Become a patreon: ⁦https://patreon.com/Serieaspotlight?⁩utm_medium=unknown&utm_source=join_link&utm_campaign=creators hare_creator&utm_content=copyLinkSpecial Shoutout to our Media Partners Benevo Bid - Check out their collection here; ⁦https://benevobid.com/⁩#acmilan #inter #juventus #torino #napoli #atalanta #bologna #fiorentina #roma #lazio #lecce #cagliari #udinese #monza #venezia #como #hellasverona #parma #empoli #genoa #football #soccer #footballpodcast #podcast PatreonYoutube: ⁦https://www.youtube.com/@serieaspotlight⁩Instagram: ⁦https://www.instagram.com/serieaspotlight/⁩Twitter: ⁦https://x.com/SerieASpotlight?⁩

Audra vs. Claire smackdown!; Victor unleashes the AI… on Matt Clark!; Noah and Sienna escape; Jack takes Jabot offline; Cane chooses Phyllis; and Victoria and Nate grow closer. Visit https://www.yrchat.com to chat with fun and friendly fans of The Young and the Restless. THIS WEEK: Ali’s Y&R Recap, The Weekly Y&R Polls, a “Who Said […]

Steve Wyss, James Eastham and Dan Roebuck look at the best bets for this weekend's matchups in LaLiga, Bundesliga, Serie A and Ligue 1. Intro - 00:00 Fade Midweek LaLiga teams? - 02:20 Napoli v Juventus - 08:47 Toulouse v Strasbourg - 13:55 Nice v Angers - 17:29 Valencia v Sevilla - 25:08 Cagliari v Roma - 27:50 Bundesliga Parlay - 30:40 Udinese v Genoa - 35:08 Serie A Title talk - 38:02 Osasuna v Levante - 42:00

Seconda serata di Coppa Italia con le big che passano il turno come da pronostico: l'Atalanta travolge il Genoa e ai quarti troverà la Juve, l'Inter passeggia sul Venezia e il Napoli porta a casa la qualificazione dopo una lunga serie di rigori ai quali partecipa come protagonista anche Milinkovic Savic nel doppio ruolo di portiere e rigorista. Commentiamo tutto con Franco Ordine del Giornale e Massimo Paganin dalla postazione di telecronaca di Sport Mediaset. Oggi una puntata di Endurance Race che guarda, inevitabilmente, all'ultimo atto della F1: ad Abu Dhabi si deciderà chi tra Piastri, Norris e Vertappen sarà campione del mondo. Ne parliamo con Gionata Ferroni e Umberto Zapelloni.

Fluent Fiction - Italian: A Christmas Mix-Up: Sweet Surprises in a Roman Hospital Find the full episode transcript, vocabulary words, and more:fluentfiction.com/it/episode/2025-12-04-23-34-02-it Story Transcript:It: Giovanni entrò di corsa nell'ospedale affollato di Roma.En: Giovanni rushed into the crowded hospital in Rome.It: Era il giorno prima di Natale e l'aria era piena di eccitazione e cori di auguri.En: It was the day before Christmas and the air was filled with excitement and the sound of well-wishers' songs.It: Le decorazioni natalizie brillavano sulle pareti: festoni di vischio e lucine colorate illuminavano i corridoi.En: Christmas decorations sparkled on the walls: garlands of mistletoe and colorful lights illuminated the corridors.It: Giovanni stringeva una scatola avvolta in carta rossa, contenente il suo prezioso Panettone fatto in casa.En: Giovanni was holding a box wrapped in red paper, containing his precious homemade Panettone.It: Era stato un suo segreto per settimane, un desiderio ardente di dimostrare le sue abilità culinarie al personale.En: It had been his secret for weeks, a burning desire to showcase his culinary skills to the staff.It: Nel caos della sala d'attesa, Giovanni si distrasse mentre salutava un amico.En: In the chaos of the waiting room, Giovanni got distracted while greeting a friend.It: Senza rendersene conto, posò la sua scatola accanto a un'altra identica.En: Without realizing, he placed his box next to another identical one.It: Con un sorriso sulle labbra, prese la scatola sbagliata e si diresse verso il reparto dove lavorava il suo amico Luca, pronto a condividere il suo dolce con i colleghi.En: With a smile on his face, he picked up the wrong box and headed toward the department where his friend Luca worked, ready to share his sweet creation with his colleagues.It: Nel frattempo, Marco, un paziente del reparto ortopedico, osservava nervoso la scatola rimasta.En: Meanwhile, Marco, a patient in the orthopedic department, nervously watched the box that remained.It: Era assolutamente orgoglioso del suo frutto di lavoro, un Pandolce genovese che aveva preparato in convalescenza.En: He was absolutely proud of his fruit of labor, a Pandolce from Genoa he had prepared during his recovery.It: Quando scoprirono di aver preso le scatole sbagliate, Giovanni e Marco erano già uno davanti all'altro nella piccola caffetteria dell'ospedale.En: When they discovered they had taken the wrong boxes, Giovanni and Marco were already facing each other in the small hospital cafeteria.It: "Luca, ho preso una scatola sbagliata!"En: "Luca, I took the wrong box!"It: esclamò Giovanni.En: exclaimed Giovanni.It: "Devo ritrovarla."En: "I need to find it."It: Marco, fermo e deciso, rispose: "Questo è il mio Pandolce.En: Marco, still and determined, replied, "This is my Pandolce.It: È fatto con amore e ricordi della mia terra."En: It's made with love and memories of my homeland."It: Giovanni studiò il dolce di Marco sospettoso.En: Giovanni studied Marco's sweet suspiciously.It: Convinto dello scambio, decise di assaggiare un pezzetto del Pandolce per confermare i suoi sospetti.En: Convinced of the switch, he decided to taste a piece of the Pandolce to confirm his suspicions.It: Il sapore degli alchechengi e delle mandorle lo colpì subito.En: The taste of dried gooseberries and almonds hit him immediately.It: "Questo ha delle mandorle!"En: "This has almonds!"It: esclamò Giovanni.En: exclaimed Giovanni.It: "Il mio Panettone ha avuto una crema d'arancia!"En: "My Panettone had an orange cream!"It: Marco esitò, guardando il pezzo di Pandolce che Giovanni aveva mordicchiato.En: Marco hesitated, looking at the piece of Pandolce that Giovanni had nibbled.It: Scoppiò una risata quando si rese conto della situazione assurda.En: He burst into laughter when he realized the absurd situation.It: "E così tu hai il mio Pandolce!"En: "So you have my Pandolce!"It: Giovanni rise, sollevato e divertito.En: Giovanni laughed, relieved and amused.It: "Sì, e tu hai il mio Panettone!"En: "Yes, and you have my Panettone!"It: Le risate rimbombarono nella caffetteria mentre i due uomini finalmente si scambiavano i dolci.En: Laughter echoed in the cafeteria as the two men finally exchanged the sweets.It: Intorno a loro si diffusero sorrisi.En: Smiles spread around them.It: Giovanni prese un respiro profondo e fece un discorso sentito sulla bellezza delle tradizioni e sull'importanza di condividerle.En: Giovanni took a deep breath and gave a heartfelt speech about the beauty of traditions and the importance of sharing them.It: "Il Natale non è essere perfetti, ma stare insieme," disse.En: "Christmas is not about being perfect but being together," he said.It: Con i cuori più leggeri, decisero di condividere entrambi i dolci con tutti nella caffetteria.En: With lighter hearts, they decided to share both sweets with everyone in the cafeteria.It: Le fette furono distribuite, e ben presto, l'intera stanza era riempita da suoni di complimenti e gioia.En: The slices were distributed, and soon, the entire room was filled with sounds of compliments and joy.It: Alla fine della giornata, Giovanni si sentì rinnovato.En: By the end of the day, Giovanni felt renewed.It: Aveva capito che la sua passione per la cucina era apprezzata e che il Natale era davvero speciale quando era condiviso.En: He realized that his passion for cooking was appreciated and that Christmas was truly special when shared.It: Seduti vicini, Giovanni, Marco e Luca brindavano alle nuove amicizie e alle risate, felici di aver trasformato una piccola confusione in un grande momento di allegria natalizia.En: Sitting together, Giovanni, Marco, and Luca toasted to new friendships and laughter, happy to have turned a small mix-up into a big moment of Christmas cheer. Vocabulary Words:crowded: affollatoexcitement: eccitazionewell-wishers: cori di augurigarlands: festonihomemade: fatto in casato showcase: dimostrareculinary: culinariechaos: caosdistracted: distrasseidenti-cal: identicato head: diresseorthopedic: ortopediconervously: nervosoproud: orgogliosorecovery: convalescenzadetermined: decisoto study: studiòsuspiciously: sospettososwitch: scambiodried gooseberries: alchechengito hit: colpìorange cream: crema d'aranciato hesitate: esitòto burst into laughter: scoppiò una risatarelieved: sollevatoamused: divertitoto echo: rimbombaronoheartfelt: sentitoto distribute: distribuiteto toast: brindavano

Join Jake and Matt as they run you through the 13th Matchweek of the Serie A, with a tight race at the top of the league, there's lots to talk about...Timestamps0:00 Intro & Rundown21:10 Milan 1–0 Lazio44:59 Roma 0–1 Napoli57:26 Pisa 0–2 Inter1:05:39 Atalanta 2–0 Fiorentina1:19:31 Juve 2–1 Cagliari1:33:02 Bologna 1–3 Cremonese1:41:04 Como 2–0 Sassuolo1:47:39 Lecce 2–1 Torino1:58:31 Genoa 2–1 Hellas Verona2:11:16 Parma 0–2 Udinese2:12:09 Predictions2:15:22 Wisdom With the Wank2:16:10 The Pride of Indonesia2:17:00 OutroBecome a patreon: ⁦https://patreon.com/Serieaspotlight?⁩utm_medium=unknown&utm_source=join_link&utm_campaign=creators hare_creator&utm_content=copyLinkSpecial Shoutout to our Media Partners Benevo Bid - Check out their collection here; ⁦https://benevobid.com/⁩#acmilan #inter #juventus #torino #napoli #atalanta #bologna #fiorentina #roma #lazio #lecce #cagliari #udinese #monza #venezia #como #hellasverona #parma #empoli #genoa #football #soccer #footballpodcast #podcast PatreonYoutube: ⁦https://www.youtube.com/@serieaspotlight⁩Instagram: ⁦https://www.instagram.com/serieaspotlight/⁩Twitter: ⁦https://x.com/SerieASpotlight?⁩

Nick and Sharon search for Noah; Thanksgiving with the Newmans and Abbotts; Ultimatum for Cane; and Danny and Christine’s wedding reception! Visit https://www.yrchat.com to chat with fun and friendly fans of The Young and the Restless. THIS WEEK: Ali’s Y&R Recap, The Weekly Y&R Polls, a “Who Said It” Quote Game, and Opening “The Chatterbox” […]

After PSV's decisive victory over Liverpool, we have to ask: did Arne Slot really just get taught a lesson from Peter Bosz? And what does such a commanding win mean for PSV's European ambitions this season?Dotun and Andy are joined by Lars to break it all down. Also on the show, what will Daniele De Rossi have to do to restore Genoa's stature? Would a strong season at a club like Strasbourg be enough to get Ben Chilwell back into England contention? What will Joan Garcia's return mean for Barcelona?Ask us a question on Twitter, Instagram and TikTok, and email us here: otc@footballramble.com.For ad-free shows, head over to our Patreon and subscribe: patreon.com/footballramble.***Please take the time to rate and review us on Apple Podcasts or wherever you get your pods. It means a great deal to the show and will make it easier for other potential listeners to find us. Thanks!*** Hosted on Acast. See acast.com/privacy for more information.

Nuestro invitado en el episodio #331 de Máximo Desempeño es Nicolás Maya, presidente del Club Deportivo Equidad y ejecutivo del fútbol con visión global que ha operado en tres continentes. Después de nueve años construyendo una carrera exitosa en McKinsey & Company, Nicolás tuvo el coraje de renunciar a la seguridad para perseguir su verdadera pasión: transformar el fútbol desde adentro. Pero el camino no fue lineal. Intentó emprender, invirtió su dinero y tiempo, y fracasó. Ese tropiezo le enseñó una lección invaluable: pedir ayuda no es rendirse, es la única forma de no rendirse. Con su sueño intacto y más sabio que antes, lideró la adquisición de seis clubes en Estados Unidos, participó en juntas directivas del Genoa de Italia y Vasco da Gama de Brasil, y hoy lidera un proyecto ambicioso que busca revolucionar el fútbol colombiano con una visión moderna, sostenible y profundamente conectada con la comunidad. Vive bajo un lema inquebrantable: "La actitud y el compromiso, no se negocian". Además, Pablo profundiza en "El Secreto de la Confianza: Haz Lo Que Más Temes", una reflexión transformadora sobre cómo se construye la confianza real. Descubre por qué nunca estarás listo para lo que tienes que hacer y el miedo no proviene de tu incapacidad sino de tu inexperiencia, cómo cada vez que evitas lo que temes le envías a tu cerebro el mensaje "no soy capaz" y tu mente responde bajando tu confianza, y por qué la neurociencia confirma que cada vez que sobrevives a algo que temías, tu cerebro actualiza su modelo de lo que eres capaz de hacer. Aprende la diferencia crucial entre confianza falsa y confianza real: una viene de elogios externos y se desmorona a la primera crítica, la otra viene de evidencia interna y es inquebrantable porque la construiste tú. Descubre por qué la confianza no es ausencia de miedo sino acción a pesar del miedo, y cómo el movimiento genera claridad mientras que la preparación infinita solo genera parálisis. Un episodio que te desafiará a preguntarte: ¿Qué has estado evitando porque esperas sentirte listo? ¿Qué conversación difícil, qué proyecto que te emociona pero te aterra, qué oportunidad estás posponiendo? ¿Cuánto te está costando mantener tu zona de confort? Tu confianza está esperándote exactamente donde está tu miedo.

Danny and Christine’s wedding!; Phyllis and Cane hook up; Claire plans revenge on Audra; and Noah/Sienna are kidnapped. Visit https://www.yrchat.com to chat with fun and friendly fans of The Young and the Restless. THIS WEEK: Ali’s Y&R Recap, The Weekly Y&R Polls, a “Who Said It” Quote Game, and Opening “The Chatterbox” to Read Fan […]

https://thecommunists.org/2025/09/24/news/genoa-dockers-convene-european-conference-non-cooperation-genocide/ This weekend, port worker delegations will meet with workers involved in the direct and/or indirect supply chain of transporting or producing war materials. Dockworkers in the Italian port of Genoa have consistently led the way in obstructing the efforts of the Nato war machine. As well as stopping arms shipments to Israel they have also stopped shipments of munitions to Ukraine and to Saudi Arabia (for use in its genocidal war against Yemen). Their example is one that should be followed by workers everywhere. Subscribe! Donate! Join us in building a bright future for humanity! www.thecommunists.org www.lalkar.org www.redyouth.org Telegram: t.me/thecommunists Twitter: twitter.com/cpgbml Soundcloud: @proletarianradio Rumble: rumble.com/c/theCommunists Odysee: odysee.com/@proletariantv:2 Facebook: www.facebook.com/cpgbml Online Shop: https://shop.thecommunists.org/ Education Program: Each one teach one! www.londonworker.org/education-programme/ Join the struggle www.thecommunists.org/join/ Donate: www.thecommunists.org/donate/

When Sydney Sweeney said "Jeans are not Controversial" Mrs. P had to investigate and what she found was astounding. From Sydney Sweeneys stalling career, to her plans with Geoff Bezos,  to the origins of Jeans in India, Britain, America. And how they were touched by the republic of Genoa, the British Ra, East India Trading Company, Mahatma Gandhi, and the prison industrial complex. And then of course back to Sydney Sweeneys GQ interview. GET THE MISCELLANEOUS IMMORALITY SHIRT HERE:

Phyllis seduces Cane; Noah and Sienna’s affair; Adam plans to humiliate Billy; Mariah shuts Tessa out; and The return of Pietro! Visit https://www.yrchat.com to chat with fun and friendly fans of The Young and the Restless. THIS WEEK: Ali’s Y&R Recap, The Weekly Y&R Polls, a “Who Said It” Quote Game, and Opening “The Chatterbox” […]

Au sommaire de Radio Foot Internationale, ce lundi 10 novembre 2025 (16h10 & 21h10 TU) : Liga, le Barça revient ; Serie A, le Napoli stoppé par Bologne, l'AC Milan freiné à Parme, la Roma de Gasperini et l'Inter en profitent pour se hisser en tête ; Platini : « Coups francs, bouclettes et petit short ». Liga, le Barça revient. Toujours sur le fil défensivement, les Blaugranas sont allés chercher une victoire importante sur le terrain du Celta Vigo (4-2). Yamal buteur, retour gagnant de Lewandowski avec un triplé, pour sa première titularisation depuis un mois. Défense fragile, attaque moins efficace ? Le Real Madrid et ses limites. Atone dans le derby contre le Rayo Vallecano, Mbappé muet, fin de série pour le Kyks, qui n'a pas eu de ballons à exploiter. Catalans et Merengues, animateurs habituels du championnat à la mécanique enrayée. L'Atlético sous pavillon américain. Le fonds d'investissement Apollo Sports Capital devient le nouvel actionnaire majoritaire du club. Les Colchoneros entrent dans une nouvelle dimension financière, des ambitions sportives redéfinies ? Serie A, le Napoli stoppé par Bologne, l'AC Milan freiné à Parme, la Roma de Gasperini et l'Inter en profitent pour se hisser en tête. Deuxième saison d'Antonio Conte sous le Vésuve, l'agacement de l'ex de l'Inter et de la Juve est perceptible, surtout après la claque reçue à Eindhoven en C1. Il exhorte ses joueurs à retrouver l'état d'esprit de la saison passée. Par ici la sortie : Vieira remercié par le Genoa, l'Atalanta se sépare de Juric. La Dea, place forte du championnat, végète à la 13e place. Platini : « Coups francs, bouclettes et petit short ». C'est le titre du livre publié par So Foot et les éditions Marabout, sur un autre « 10 » de légende, à l'occasion des 70 ans du milieu de terrain. Retour sur la carrière de l'ex-capitaine des bleus, et élégant joueur de la Juve. Le foot aux footballeurs aussi. Platoche nourrit le projet d'un musée du foot ouvrier à Jœuf, sa ville natale. Pour débattre avec Annie Gasnier : Chérif Ghemmour, Étienne Moatti et Éric Rabesandratana. Technique/Réalisation : Laurent Salerno --  David Fintzel/Pierre Guérin.

New Noah revealed… and he's having an affair with Sienna! Claire goes all the way with Holden… and back… to Kyle! Visit https://www.yrchat.com to chat with fun and friendly fans of The Young and the Restless. THIS WEEK: Ali’s Y&R Recap, The Weekly Y&R Polls, a “Who Said It” Quote Game, and Opening “The Chatterbox” […]